Keyphrases
Metastasis
100%
Isolated Limb Infusion
100%
In-transit Melanoma
100%
Nonagenarian Patients
100%
Octogenarian Patients
100%
Young Patients
50%
Progression-free Survival
25%
Melanoma-specific Survival
25%
Cytotoxic Drugs
12%
Drug Combination
12%
Actinomycin D
12%
Melanoma
12%
Melphalan
12%
Overall Survival
12%
Upper Limb
12%
Limb Amputation
12%
Young Cohort
12%
Control Rate
12%
No Toxicity
12%
Toxicity Grades
12%
Octogenarians
12%
Regional Control
12%
Response Control
12%
American Joint Committee on Cancer
12%
Seventh Edition
12%
Distant Progression
12%
Nonagenarians
12%
Medicine and Dentistry
Infusion
100%
Limb
100%
Metastatic Melanoma
100%
Melanoma
50%
Progression Free Survival
33%
Malignant Neoplasm
16%
Melphalan
16%
Overall Survival
16%
Upper Limb
16%
Limb Amputation
16%
Dactinomycin
16%
Combination Drug
16%
Diseases
16%
Joint Committee
16%
Cytotoxic Agent
16%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Metastatic Melanoma
100%
Progression Free Survival
66%
Malignant Neoplasm
33%
Overall Survival
33%
Dactinomycin
33%
Melphalan
33%
Combination Drug
33%
Diseases
33%
Cytotoxic Agent
33%